From a user-friendly flow cytometer with performance similar to systems costing 5 times more to microfluidic droplets that serve as tiny test tubes to a system targeting a $100 genome, revolutionary life sciences technologies are changing the rules of the game in biomedical research. Their accessibility and affordability are empowering individual scientists to conduct research that was formerly not feasible and also threatening the research status quo. The CEOs responsible for these breakthroughs will describe the radical innovations, new perspectives and diverse disciplines underlying their technologies, as well as challenges to development and commercialization of these novel approaches.

• Show how new tools technologies are transforming biomedical research and challenging the status quo
• Describe the fresh perspectives and diverse disciplines needed to develop revolutionary technologies
• Illustrate how to overcome the challenges of developing and commercializing revolutionary approaches